At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 25 enrolled
Drug / intervention
Tasimelteon +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder
In Brief
A Phase 2 clinical trial evaluating Tasimelteon and Placebo for Jet Lag Disorder. Completed, enrolled 25 participants across 3 sites.
Detailed Summary
A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsJet Lag Disorder
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2017201820192020202120222023202420252026
Enrollment StartJul 2016
First PostedSep 2017
Primary CompletionNov 2017
TodayJul 2026
First PostedSep 25, 2017
Enrollment StartJul 1, 2016
Primary CompletionNov 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 8.8 years ago
Interventions
Tasimelteondrug
capsule
Placebodrug
capsule